View Author
scopus: 7005712867

Kuis, W.

(Wietse Kuis)


patient disease arthritis treatment hsp 60 muscle trial follow-up study group dmard response outcome muscle tissue remission disease activity range tissue cytokine dm patients idiopathic arthritis control ssz trial netherland onset muscle biopsy samples duration activity analysis protein assessment sample ssz group range 0 idiopathic blood stimulation score production dmard treatment result antigen joint biopsy factor follow-up study polyarticular ssz trial inclusion rheumatol medication number disease remission ssz treatment compliance ssz patients follow-up period cytokine production treatment groups expression article il -10 therapy mycobacterial self hsp 60 period children sulfasalazine department rheum rheumatology oligoarticular dermatomyositi physician plac group t cells prakken self antigens variable plac patients jia patients




2 Most Recent Publications

Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis (Article)
Elst, E.F. Klein, M. Jager, W. de Kamphuis, S.S.M. Wedderburn, L.R. Zee, R. van der Albani, S. Kuis, W. Prakken, B.J.
2008-02-01
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: Sustained benefits of early sulfasalazine treatment (Article)
Rossum, M.A.J. van Soesbergen, R.M. van Oostveen, J.C.M. Kuis, W. Dijkmans, B.A.C. Boers, M. Zwinderman, A.H. Fiselier, T.J.W. Franssen, M.J.A.M. Cate, R. ten Suijlekom-Smit, L.W.A. van Wulffraat, N.M. Luijk, W.H.J. van
2007-11-01